Suppr超能文献

国际疾病分类第九版(ICD-9)对艰难梭菌感染编码的准确性:一项回顾性队列研究

Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort.

作者信息

Scheurer D B, Hicks L S, Cook E F, Schnipper J L

机构信息

Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Epidemiol Infect. 2007 Aug;135(6):1010-3. doi: 10.1017/S0950268806007655. Epub 2006 Dec 7.

Abstract

Clostridium difficile (C. diff) is a major nosocomial problem. Epidemiological surveillance of the disease can be accomplished by microbiological or administrative data. Microbiological tracking is problematic since it does not always translate into clinical disease, and it is not always available. Tracking by administrative data is attractive, but ICD-9 code accuracy for C. diff is unknown. By using a large administrative database of hospitalized patients with C. diff (by ICD-9 code or cytotoxic assay), this study found that the sensitivity, specificity, positive, and negative predictive values of ICD-9 coding were 71%, 99%, 87%, and 96% respectively (using micro data as the gold standard). When only using symptomatic patients the sensitivity increased to 82% and when only using symptomatic patients whose test results were available at discharge, the sensitivity increased to 88%. C. diff ICD-9 codes closely approximate true C. diff infection, especially in symptomatic patients whose test results are available at the time of discharge, and can therefore be used as a reasonable alternative to microbiological data for tracking purposes.

摘要

艰难梭菌(C. diff)是一个主要的医院感染问题。该疾病的流行病学监测可通过微生物学或管理数据来完成。微生物学追踪存在问题,因为它并不总是转化为临床疾病,而且并非总是可用。通过管理数据进行追踪很有吸引力,但C. diff的ICD - 9编码准确性尚不清楚。通过使用一个大型住院艰难梭菌患者管理数据库(通过ICD - 9编码或细胞毒性检测),本研究发现ICD - 9编码的敏感性、特异性、阳性预测值和阴性预测值分别为71%、99%、87%和96%(以微观数据作为金标准)。仅使用有症状患者时,敏感性提高到82%,而仅使用出院时检测结果可用的有症状患者时,敏感性提高到88%。C. diff的ICD - 9编码与真正的艰难梭菌感染非常接近,尤其是在出院时检测结果可用的有症状患者中,因此可作为追踪目的的微生物学数据的合理替代方法。

相似文献

1
Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort.
Epidemiol Infect. 2007 Aug;135(6):1010-3. doi: 10.1017/S0950268806007655. Epub 2006 Dec 7.
3
Accuracy of coding for possible warfarin complications in hospital discharge abstracts.
Thromb Res. 2006;118(2):253-62. doi: 10.1016/j.thromres.2005.06.015. Epub 2005 Aug 2.
5
Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.
Arch Surg. 2007 Jul;142(7):624-31; discussion 631. doi: 10.1001/archsurg.142.7.624.
6
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.
Am J Gastroenterol. 2008 Jun;103(6):1443-50. doi: 10.1111/j.1572-0241.2007.01780.x. Epub 2008 May 29.
8
The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis.
J Hosp Infect. 2011 Jan;77(1):1-6. doi: 10.1016/j.jhin.2010.07.024. Epub 2010 Dec 8.
9
Clostridium difficile surveillance: a multicenter comparison of LabID events and use of standard definitions.
Infect Control Hosp Epidemiol. 2013 Jun;34(6):653-5. doi: 10.1086/670642.

引用本文的文献

1
Anti-interleukin-23 treatment linked to improved infection survival.
Gut Microbes. 2025 Dec;17(1):2480195. doi: 10.1080/19490976.2025.2480195. Epub 2025 Mar 21.
2
Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework.
Pharmacoeconomics. 2024 Oct;42(10):1127-1144. doi: 10.1007/s40273-024-01400-z. Epub 2024 Jul 5.
3
Colon Cancer Risk Following Intestinal Infection: A Longitudinal Cohort Study.
J Clin Med Res. 2023 Jun;15(6):310-320. doi: 10.14740/jocmr4919. Epub 2023 Jun 29.
4
Evidence of within-facility patient-patient infection spread across diverse settings.
Epidemiol Infect. 2022 Dec 11;151:e4. doi: 10.1017/S0950268822001893.
7
The Risk of Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts.
Antibiotics (Basel). 2022 Feb 23;11(3):295. doi: 10.3390/antibiotics11030295.
8
Rate and predictors of 30-day readmission for : a United States analysis.
Ann Med. 2022 Dec;54(1):150-158. doi: 10.1080/07853890.2021.2023211.

本文引用的文献

1
ICD-9 codes and surveillance for Clostridium difficile-associated disease.
Emerg Infect Dis. 2006 Oct;12(10):1576-9. doi: 10.3201/eid1210.060016.
2
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.
Emerg Infect Dis. 2006 Mar;12(3):409-15. doi: 10.3201/eid1205.051064.
3
An epidemic, toxin gene-variant strain of Clostridium difficile.
N Engl J Med. 2005 Dec 8;353(23):2433-41. doi: 10.1056/NEJMoa051590. Epub 2005 Dec 1.
7
Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.
J Infect Dis. 2004 May 1;189(9):1585-9. doi: 10.1086/383045. Epub 2004 Apr 20.
8
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.
Clin Infect Dis. 2002 Feb 1;34(3):346-53. doi: 10.1086/338260. Epub 2001 Dec 17.
10
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
N Engl J Med. 2000 Feb 10;342(6):390-7. doi: 10.1056/NEJM200002103420604.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验